F. Hunziker and Co AG Revenue and Competitors

Dietikon, USA

Location

N/A

Total Funding

Food

Industry

Estimated Revenue & Valuation

  • F. Hunziker and Co AG's estimated annual revenue is currently $15.8M per year.(i)
  • F. Hunziker and Co AG's estimated revenue per employee is $243,000

Employee Data

  • F. Hunziker and Co AG has 65 Employees.(i)
  • F. Hunziker and Co AG grew their employee count by 7% last year.

F. Hunziker and Co AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.6M609%N/AN/A
#2
$15.8M653%N/AN/A
#3
$29.7M1105%$184.4MN/A
#4
$64.4M21736%N/AN/A
#5
$17M703%N/AN/A
#6
$24.8M925%N/AN/A
#7
$52.9M17811%N/AN/A
#8
$63.6M2145%N/AN/A
#9
$14.8M617%N/AN/A
#10
$13.6M56-7%N/AN/A
Add Company

What Is F. Hunziker and Co AG?

Seit 1930 gehört F. Hunziker + Co AG, eine vollständig unabhängige und eigenfinanzierte Schweizer Familienholding, zu den international führenden Innovationstreibern in den Bereichen funktionelle Produkte wie Nahrungsergänzungsmittel, Medizinprodukte, rezeptfreie Arzneimittel und Lebensmittel. Unser Sortiment verbindet Geschmack mit Funktion und bietet dabei mehr als nur süssen Genuss. So hilft der Grossteil unserer Produkte unter anderem bei der Vorbeugung und Behandlung gesundheitlicher Beschwerden.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$15.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

F. Hunziker and Co AG News

2022-04-19 - No evidence for disruption of reconsolidation of conditioned ...

EDA was measured via two Ag/AgCl electrodes attached to distal ... Shapiro, F. EMDR treatment: Overview and integration. in EMDR as an...

2022-04-17 - Adult Gummy Vitamin Market SWOT Analysis by Size, Status ...

... Santa Cruz Nutritionals, Smarty Pants, F. Hunziker + Co AG, Vitakem Nutraceutical Inc, Nature?s Way, ABH Labs & Zanon Vitamec.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A9023%N/A
#2
$11.7M1173%N/A
#3
$19.7M179-4%N/A
#4
$47.9M19223%N/A
#5
$85.4M30114%N/A